Diagnostic accuracy of novel blood-biomarkers for Parkinson's disease

Diagnostic accuracy of novel blood-biomarkers for Parkinson's disease - Diagnostic biomarkers for Parkinson's disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON56654

Enrollment

Registered

2024-03-14

Start date

2024-10-02

Completion date

Unknown

Last updated

2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Parkinson's disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Subject is an adult, at least 18 years of age. - Subject can read and understand Dutch. - Subject has completed CMO-approved Informed Consent. - Subject is willing, competent, and able to comply with all aspects of the protocol, including biospecimen collections.

Exclusion criteria

Exclusion criteria: - Subject is pregnant or breastfeeding. - Subject has Parkinson*s disease.

Design outcomes

Primary

Measure	Time frame
Minimal clinical data extracted from questionnaires and storage of patient material (cells, serum, plasma, DNA, RNA).	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results